Well said.
The R&D spend across both divisions looks to be a larger % of revenue than previously (including the Accountancy division which has been sold).
I was surpised at no divvy. Though perhaps this was factored into the special divvy.
Also no reference on the recent price increases since Jan-1. I would have thought this was a key item for their slide deck?
I'm happy to hold - I rate mgmt highly, and fairly defensive earnings/user base.
Ann: Roadshow Slide Presentattion FY22, page-4
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RKN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
0.005(0.90%) |
Mkt cap ! $63.44M | |||
| Open | High | Low | Value | Volume |
| 56.0¢ | 56.0¢ | 56.0¢ | $2.015K | 3.599K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1401 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 15000 | 1 |
View Market Depth
| Last trade - 14.47pm 13/11/2024 (20 minute delay) ? |
| RKN (ASX) Chart |